Fig 8. Kaplan Meier survival curves for risk estimation in the CRC stage III patient cohort based on hybrid biomarker RSH.
RSH combines the protein concentration balance with age of the patient to stratify high and low risk patients. Patients with RSH <mean(RSH) have low survival probability as compared to patients with RSH >mean(RSH), with HR = 40.11 and p-value = 0.0003.